Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies.

Avivi, Irit; Yekutiel, Naama; Shragai, Tamir; Cohen, Yael C; Grunspan, Moshe; Rivlin, Noa; Frankel, Neta; Cohen, Raanan; Weil, Clara; Chodick, Gabriel

Avivi, Irit; Yekutiel, Naama; Shragai, Tamir; Cohen, Yael C; Grunspan, Moshe; Rivlin, Noa; Frankel, Neta; Cohen, Raanan; Weil, Clara; Chodick, Gabriel.

Afiliação

Avivi I; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. iritavi@tlvmc.gov.il.
Yekutiel N; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. iritavi@tlvmc.gov.il.
Shragai T; Maccabi Institute of Research and Innovation (Maccabitech), Maccabi Health Care Services, Tel-Aviv, Israel.
Cohen YC; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Grunspan M; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Rivlin N; Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Frankel N; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Cohen R; Abbvie Inc., Hod Hasharon, Israel.
Weil C; Abbvie Inc., Hod Hasharon, Israel.
Chodick G; Abbvie Inc., Hod Hasharon, Israel.

Ann Hematol ; 102(11): 3075-3081, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37646848

Palavras-chave

Multiple myeloma; Relpase/refractory multiple myeloma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google